NVUS Market Cap History
Below is a table of the NVUS market cap history going back to 5/11/2017:

Date NVUS Market Cap
5/11/201716.05M
8/4/201727.77M
11/6/201729.79M
3/23/201851.83M
5/7/201840.64M
8/3/201849.47M
11/8/201841.93M
3/22/201940.10M
5/10/201930.31M
8/12/201910.68M
11/11/20199.34M

Also see: NVUS Shares Outstanding History
and NVUS YTD Return
NVUS Historical Market Cap:
-19.46% CAGR
NVUS Historical Market Cap: +-19.46% CAGR

Mouse over chart for data details
5/11/20178/4/201711/6/20173/23/20185/7/20188/3/201811/8/20183/22/20195/10/20198/12/201911/11/2019
Novus Therapeutics is a pharmaceutical company focused on developing products for patients with disorders of the ear, nose, and throat. Co. has two platform technologies. Co.'s primary program (OP0201) is a surfactant-based nasal aerosol drug-device combination product candidate being developed as a treatment option for patients at risk for, or with, otitis media, which is middle ear inflammation and effusion with or without infection. Co. also has a foam-based drug delivery technology platform (OP01xx), which may be developed to deliver drugs into the ear, nasal, and sinus cavities. We show 11 historical shares outstanding datapoints in our NVUS shares outstanding history coverage, used to compute NVUS market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing NVUS market cap history over the course of time is important for investors interested in comparing NVUS's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of NVUS versus a peer is one thing; comparing NVUS market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like NVUS can fluctuate over the course of history. With this page we aim to empower investors researching NVUS by allowing them to research the NVUS market cap history.
Quotes delayed 20 minutes
Get Free SEC filing alerts for NVUS:
NVUS SEC Filing Email Alerts ServiceExternal link
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Novus Therapeutics (NVUS) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

NXTM Market Cap History
NYMX Market Cap History
OBLN Market Cap History
OCUL Market Cap History
ODT Market Cap History
OFIX Market Cap History
OHRP Market Cap History
OMED Market Cap History
OMER Market Cap History
OMI Market Cap History
More Healthcare companies »

 

NVUS Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2019, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.